The Connected Clinician: Top Stories of the Week for October 27

OCTOBER 27, 2017
Kevin Kunzmann
Problems must be targeted before solutions can be met. The challenge of clinical investigation is in fully understanding what conditions are causing in patients before even developing a strategy in combating the condition. Much of MD Magazine's top stories this week pertained to uncovering problems. From understanding the context of increasing US heart failure rates, to expanding on the link between centralized retinal thickness (CRT) and vision loss, our content this week focused on health care's harder questions.

In case you missed them, here's our Connected Clinician Top Stories of the Week:

Air Pollution Deaths Reach New Global Highs

Ambient air pollution-related deaths now total more annually than AIDS, tuberculosis, and malaria combined.

Sepsis Screening Possibly Linked to C. difficile Infection

Broad spectrum antibiotics may be to blame for healthcare facility-onset CDI. 

Where to Target HIV Prevention and Care to Reach MSM

HIV infection is hyperendemic among MSM throughout many areas of the US, specifically in the South.

Revised Declaration of Geneva Could Replace Hippocratic Oath

The most recent WMA revised declaration brings attention to possible physician burnout.

The Prevalence of Adult Onset ADHD, Reconsidered

Results showed that more than 80% of participants had their symptoms explained by other factors.

Many Patients Unaware of Risks of Double Dosing OTC Cold/Flu Medications

It’s imperative healthcare providers strive to have a conversation with patients when prescribing medication.

Hospital Infection Control Uses EHR to Track C. Difficile

EHR tracks down a source of a common hospital-acquired infection tracing patient movements.

Once Daily Single-Tablet HIV-1 Therapy Achieves Primary Endpoint

Janssen’s darunavir-based STR, if approved, will be the only complete simplified regimen for HIV-1 in ART-naïve patients.

Alkermes Announces Schizophrenia Therapy Studies

ARISTADA is being investigated as a possible extended-release injectable suspension, as well as INVEGA SUSTENNA in patients with acute exacerbation of schizophrenia.

Plazomicin Submitted for NDA in Treatment of Complicated UTI

The drug has the potential to treat certain multi-drug resistant gram-negative pathogens like CRE.

Related Coverage >>>
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.